Related Experiment Videos
Nonallograft osteoconductive bone graft substitutes
1Department of Orthopaedic Surgery, University of Texas Southwestern Medical School, Dallas 75390-8883, USA.
Clinical Orthopaedics and Related Research
|April 9, 2002
Summary
Synthetic bone graft substitutes offer advantages like unlimited supply but have variable performance. Despite clinical use, few trials exist, leading to their use as bone graft extenders and carriers.
Area of Science:
- Orthopaedic surgery
- Biomaterials science
- Regenerative medicine
Background:
- Bone grafting is common, with synthetic substitutes gaining market share.
- Current synthetic bone graft substitutes have limited clinical trial data despite years of use.
- These materials include hydroxyapatite, tricalcium phosphate, and calcium sulfate, with varying properties.
Purpose of the Study:
- To review the composition, histology, indications, and clinical experience of synthetic bone graft substitutes.
- To highlight the advantages and disadvantages of synthetic bone graft substitutes.
- To discuss the evolving role of synthetic bone graft substitutes in orthopaedic applications.
Main Methods:
- Review of existing literature on synthetic bone graft substitutes.
- Analysis of composition, fabrication, and properties of various synthetic materials.
- Examination of clinical data and indications for approved orthopaedic bone graft substitutes.
Main Results:
- Synthetic bone graft substitutes offer benefits like availability and sterilization but differ in osteoconductivity.
- Ceramic implants have drawbacks including brittleness and variable resorption, impacting bone remodeling.
- Their primary use has shifted towards bone graft extenders and pharmaceutical carriers.
Conclusions:
- Synthetic bone graft substitutes present a growing alternative to traditional grafts but require further well-designed clinical trials.
- Understanding material properties is crucial for optimizing their use in orthopaedic procedures.
- Their role is evolving, with a focus on enhancing autografts and delivering therapeutics.